Antihypertensive Treatment in Masked Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

February 14, 2017

Primary Completion Date

October 30, 2021

Study Completion Date

March 30, 2022

Conditions
Masked Hypertension
Interventions
DRUG

Allisartan Isoproxil

Allisartan Isoproxil 80mg once daily taken in the morning during 8:00-9:00. To achieve the target blood pressure allisartan isoproxil may be doubled to 160mg once a day. If necessary, amlodipine 2.5mg may be combined with allisartan isoproxil. Duration: 12 months.

DRUG

Placebo

Corresponding placebo once daily taken in the morning during 8:00-9:00. Duration: 12 months.

Trial Locations (1)

200025

Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Yan Li

OTHER

NCT02893358 - Antihypertensive Treatment in Masked Hypertension | Biotech Hunter | Biotech Hunter